HomeCompareEMITF vs EPRT

EMITF vs EPRT: Dividend Comparison 2026

EMITF yields 111.11% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EMITF wins by $6.01M in total portfolio value
10 years
EMITF
EMITF
● Live price
111.11%
Share price
$1.80
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.07M
Annual income
$2,192,447.17
Full EMITF calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — EMITF vs EPRT

📍 EMITF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMITFEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMITF + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EMITF pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMITF
Annual income on $10K today (after 15% tax)
$9,444.44/yr
After 10yr DRIP, annual income (after tax)
$1,863,580.09/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, EMITF beats the other by $1,852,665.47/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMITF + EPRT for your $10,000?

EMITF: 50%EPRT: 50%
100% EPRT50/50100% EMITF
Portfolio after 10yr
$3.07M
Annual income
$1,102,643.94/yr
Blended yield
35.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

EMITF
No analyst data
Altman Z
-0.0
Piotroski
3/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMITF buys
0
EPRT buys
0
No recent congressional trades found for EMITF or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMITFEPRT
Forward yield111.11%3.92%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$6.07M$63.4K
Annual income after 10y$2,192,447.17$12,840.73
Total dividends collected$5.48M$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: EMITF vs EPRT ($10,000, DRIP)

YearEMITF PortfolioEMITF Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$21,811$11,111.11$11,205$505.18+$10.6KEMITF
2$45,987$22,649.13$12,672$682.46+$33.3KEMITF
3$93,836$44,629.82$14,490$930.48+$79.3KEMITF
4$185,513$85,108.97$16,786$1,282.69+$168.7KEMITF
5$355,752$157,252.56$19,753$1,791.56+$336.0KEMITF
6$662,484$281,829.11$23,677$2,541.64+$638.8KEMITF
7$1,199,347$490,489.82$29,008$3,672.99+$1.17MEMITF
8$2,113,183$829,881.38$36,463$5,425.08+$2.08MEMITF
9$3,627,652$1,366,546.40$47,238$8,221.57+$3.58MEMITF
10$6,074,035$2,192,447.17$63,385$12,840.73+$6.01MEMITF

EMITF vs EPRT: Complete Analysis 2026

EMITFStock

Elbit Imaging Ltd., together with its subsidiaries, engages in the development, production, and marketing of therapeutic medical systems for performing non-invasive treatments on the human body in the North and South America, Europe, Asia, and Oceania. The company offers treatment-oriented medical systems with ultrasound beam and magnetic resonance imaging for noninvasive treatments in human body. It also offers medical products based on stem cells derived primarily from umbilical cord blood and intended for bone marrow transplantation in patients with leukemia or lymph node cancer, non-malignant blood diseases, and metabolic genetic diseases. In addition, the company is involved in the sale of plots and villas in India. The company was incorporated in 1996 and is headquartered in Petach Tikva, Israel.

Full EMITF Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this EMITF vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMITF vs SCHDEMITF vs JEPIEMITF vs OEMITF vs KOEMITF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.